Researchers from KAIST, UC Berkeley, and Gladstone Institutes have developed a CRISPR-based diagnostic that distinguishes multiple viruses and variants simultaneously by analyzing the reaction speed ...

Researchers at Nagoya University have developed the SMART platform, which screens enzyme variants at the single-molecule level, significantly reducing time and cost compared with conventional methods.

JEV has been found in Asia and the Western Pacific, where several countries have active mosquito and swine surveillance ...

Researchers developed a wearable electrochemical patch that detects six vitamins in sweat at nanomolar levels, combining ...

Brazilian researchers have developed an electrochemical sensor that can detect pancreatic cancer in its early stages. The ...

Affinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced a pilot study with Brooke Army ...

Sweet grapes do not happen by accident. As berries ripen, the plant has to move, make, and store sugars with remarkable ...

For years, AI drug discovery has been judged on benchmark performance. Now, a set of studies shows what happens when those ...

MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

Device developed at the University of São Paulo aims to enable rapid and accessible diagnosis of pancreatic cancer, thereby increasing the chances of effective treatment.

This study characterizes several novel activities of SARS-CoV-2 helicase nsp13, providing valuable insights into potentially new functions of this essential RNA-processing enzyme in the virus life ...

Dpcr Market To Surpass US$14.34 Billion By 2031, Propelled By Escalating Demand For High‐Precision Genetic Analysis - New Industry Research By The Insight Partners.. Growing demand for sensitive and ...